Driving CAR T-cell Therapy in New Directions
Featuring insights from Carl H. June, MD, FAACR, this post covers the ongoing challenges facing CAR T-cell therapy and...
Featuring insights from Carl H. June, MD, FAACR, this post covers the ongoing challenges facing CAR T-cell therapy and...
Special programs for high school and undergraduate students at the AACR Annual Meeting provide valuable opportunities for learning, networking,...
A recently approved first-line therapy and novel insights into optimizing treatment strategies may offer new options for esophageal cancer...
A congressional forum hosted by Senators Tammy Baldwin and Peter Welch examined how NIH funding cuts could impact cancer...
Key details about the program, registration, networking opportunities, and more, to help attendees prepare for the AACR Annual Meeting...
In the first quarter of 2025, the FDA issued 13 approvals for oncology treatments, covering nine types of cancer...
This month, the editors of AACR's journals tout studies showcasing the immunostimulatory impact of senescent cancer cells, a novel...
A promising new personalized vaccine headlines several recent breakthroughs that highlight progress in kidney cancer research.
After Craig Schumpert learned he had lung cancer that had spread to his brain, bones, and lymph nodes, he...
The CheckPoints is a band comprised of cancer researchers, medical oncologists, and other professionals in the field of immuno-oncology.
Multiple myeloma can be tricky to treat, but many treatment options exist, and new research is constantly supporting more.